UPCOMING WEBINAR

Upcoming Webinar

The Emerging Role of Stereotactic Ablative Radiotherapy (SABR) for Pediatric and AYA Malignancies

April 24, 2025, 12:00pm Eastern Time

Presented by:

  • Raj Singh, MD
  • Moderator: Rituraj Upadhyay, MD

Description and Objectives:

Webinar Description: 

While SABR has been well established in the setting of adult patients with cancer for a number of years, its potential applications for pediatric/adolescent and young adult (AYA) malignancies is a growing area of clinical research and interest. This webinar will review the currently available data on clinical outcomes with SABR for pediatric and AYA patients with cancer in settings such as locally recurrent primary disease, oligometastatic disease, and metastatic disease with the aim of palliation of symptoms and future clinical and research directions. We will review case examples for each setting as well to give attendees an understanding of patient selection/considerations and dose/fractionation selection.


Educational Objectives: 

Review current available data on outcomes with SABR for pediatric and AYA patients with malignancies and future research directions

Develop a framework for patient selection criteria for SABR and considerations for SABR planning

Review case examples of SABR for locally recurrent primary disease, aggressive local ablative therapy in the setting of oligometastatic disease, and SABR for palliation of symptoms from metastatic disease

Register Now

Satisfactory Completion

  • Learners must complete an online evaluation form within 45-days of live webinar to receive a certificate of completion.
  • You must attend the entire webinar as partial credit is not available.
  • If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Statement of Need

Advances in the applications, technologies and methodologies of stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) continue to evolve rapidly and the delivery of treatment has become more complex, making it imperative that oncology professionals remain current in the state-of-the-art techniques. The Radiosurgery Society is committed to providing educational programming that creates a forum for global collaboration to improve professional practice by increasing their level of knowledge, as required to improve competency in the field of oncology.

Target Audience

The target audience includes radiation oncologists, surgeons, medical physicists, nurses, residents, trainees and healthcare providers in the field of SRS/SBRT, radiation oncology and medical oncology.

Accreditation Statements

Pending Review

Credit Designation Statements

Pending Review

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

  • Raj Singh, MD - Pending
  • Moderator: Rituraj Upadhyay, MD - Pending

Acknowledgement of Financial Commercial Support

<em>No financial commercial support was received for this educational activity.</em>

Acknowledgement of In-Kind Commercial Support

<em>No in-kind commercial support was received for this educational activity.</em>

Certificate of Participation

If continuing education credits are applicable for this webinar, a certificate will be issued upon completion of course requirements, including the online evaluation, enabling you to register your credit with the appropriate licensing boards or associations. Evaluations must be completed within 45 days of live webinar.

Please contact webinars@therss.org if you have questions.